AR and androgen insensitivity syndrome: In vitro studies of genital skin-derived fibroblasts (GSFs) from patients with androgen insensitivity syndrome (AIS) type II and DAAM2 variants showed reduced dihydrotestosterone (DHT)-induced AR activity compared to WT GSFs [74].